Skip to main content

Table 6 Differentially methylated regions (DMRs) and differentially variable regions (DVRs) in meta-analyses. DMRs and DVRs in the PBMC meta-analysis (i.e., including the Chile PBMC study, Bangladesh 450 K study, and Bangladesh 850 K study) and PBMC + buccal cell meta-analysis (i.e., including the Chile buccal cell study) adjusted for age, smoking status, cell type proportions, and sex (in the Chile studies). Genes identified in multiple meta-analyses are bolded

From: Exposure to arsenic at different life-stages and DNA methylation meta-analysis in buccal cells and leukocytes

Chromosome

Start

End

N probes

Sidak p

Gene

DMRs

 PBMCs

  10

134,150,451

134,150,760

7

1.47E-09

LRRC27

  7

27,231,819

27,232,150

3

1.20E-07

HOXA13

  10

91,295,045

91,295,650

11

1.35E-07

SLC16A12

  7

27,225,733

27,226,148

7

8.99E-07

HOXA11-AS

  8

23,563,925

23,564,294

8

1.26E-05

NKX2–6

  1

203,320,190

203,320,541

6

1.35E-05

FMOD

  11

15,095,017

15,095,178

6

5.68E-05

CALCB

  16

88,747,591

88,747,919

4

7.15E-05

SNAI3-AS1;SNAI3

  15

83,953,690

83,953,883

10

3.77E-05

BNC1

  13

51,640,142

51,640,442

5

1.15E-04

GUCY1B2

  19

49,220,102

49,220,235

4

5.36E-04

MAMSTR

 PBMCs + buccal cells

  10

134,150,451

134,150,760

7

3.42E-10

LRRC27

  7

27,225,543

27,226,148

8

4.17E-09

HOXA11-AS

  7

27,231,819

27,232,150

3

1.04E-08

HOXA13

  1

203,320,190

203,320,541

6

3.72E-08

FMOD

  11

15,095,017

15,095,178

6

9.60E-07

CALCB

  16

88,747,591

88,747,919

4

3.93E-07

SNAI3-AS1;SNAI3

  8

23,563,925

23,564,294

8

2.69E-05

NKX2–6

  2

207,139,131

207,139,445

6

0.001

ZDBF2

  1

247,537,159

247,537,369

3

1.75E-05

LOC107985115

  8

145,638,881

145,639,181

3

3.34E-05

SLC39A4

  16

85,518,901

85,519,061

3

0.073

GSE1

  17

17,603,837

17,604,184

3

5.40E-05

RAI1

  6

28,584,003

28,584,155

10

0.001

ZBED9

  19

49,220,102

49,220,235

4

5.36E-04

MAMSTR

  7

120,968,877

120,969,174

8

1.20E-04

WNT16

  19

44,488,121

44,488,269

5

9.10E-04

ZNF155

DVRs

 PBMCs

  22

19,929,066

19,929,557

9

4.27E-13

TXNRD2;COMT;TXNRD2

  16

1,844,927

1,845,113

6

3.56E-11

IGFALS

  22

39,784,481

39,784,982

5

7.84E-09

SYNGR1

  3

8,809,306

8,809,715

4

6.66E-08

OXTR

  2

947,515

947,634

3

6.36E-07

SNTG2

  2

48,844,728

48,844,984

6

5.84E-06

STON1-GTF2A1L;GTF2A1L

  3

48,700,269

48,700,498

8

2.02E-05

CELSR3

  12

9,217,529

9,217,859

7

4.45E-05

LINC00612;A2M-AS1

  16

53,407,423

53,407,808

5

7.37E-05

LOC102723373

  10

134,150,451

134,150,760

7

6.52E-05

LRRC27

  6

90,597,340

90,597,591

4

1.20E-04

GJA10

 PBMCs + buccal cells

  22

19,929,066

19,929,557

9

5.12E-13

TXNRD2;COMT;TXNRD2

  6

30,038,882

30,039,600

25

1.49E-09

RNF39

  6

32,064,656

32,065,043

16

4.68E-06

TNXB

  3

8,809,306

8,809,715

4

1.90E-07

OXTR

  5

178,986,291

178,986,728

6

1.16E-05

RUFY1

  6

31,651,070

31,651,291

5

0.079

LY6G5C

  22

39,784,769

39,784,982

3

1.57E-05

SYNGR1

  2

48,844,728

48,844,984

6

1.45E-05

STON1-GTF2A1L;GTF2A1L

  6

32,551,749

32,552,042

3

1.72E-05

HLA-DRB1

  12

9,217,529

9,217,859

7

4.29E-05

LINC00612;A2M-AS1

  2

947,515

947,634

3

7.33E-05

SNTG2

  18

59,221,320

59,221,601

3

3.20E-05

CDH20

  16

1,844,927

1,845,113

6

6.80E-05

IGFALS

  6

168,106,055

168,106,326

4

5.79E-05

LINC02487

  16

53,407,423

53,407,753

4

5.41E-04

LOC102723373

  7

157,667,762

157,668,051

4

8.85E-05

PTPRN2

  10

134,150,451

134,150,760

7

8.96E-05

LRRC27

  19

37,825,307

37,825,446

6

4.27E-04

ZNF875

  19

36,246,816

36,246,906

3

8.87E-04

HSPB6

  1. DMP differentially methylated position, DVP differentially variable position